Built on over 80 years of experience, SK pharmteco is a trusted CDMO partner specializing in the process development and manufacture of small molecules (APIs, intermediates, registered starting materials) and cell and gene therapies for organizations across the pharmaceutical and biopharmaceutical industries. Our integrated offerings span process and analytical method development (including stand-alone analytical services) to scale-up and optimization, validation, and commercial production.
Our global operations have the capabilities and capacity to support your needs from development through commercial production. We operate seven development and manufacturing facilities across the United States, Korea, Ireland, and France, As a subsidiary of SK Inc., the strategic investment company for SK Group, SK pharmteco is backed by the strength and stability of South Korea’s second-largest conglomerate. Together, we work to embody SK Group’s shared goal of fostering progress and innovation to improve the lives of people around the world.
